NCT06860646Recruiting
Myocardial Infarction in the Elderly
Hospital Registry of Patients with Myocardial Infarction in Individuals Aged 75 Years and Older
Source: ClinicalTrials.gov · Last updated 6 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
An observational registry study of patients aged 75 years and older with an established diagnosis of myocardial infarction, initiated in 2020, with an assessment of clinical, instrumental, demographic and prognostic data. Statistical analysis was performed using the StatTech v. 4.5.0 program (developer - StatTech LLC, Russia). Differences were considered statistically significant at p \<0.05.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 28 Feb 2025
- Start date
- 1 Sept 2020
- Primary completion date
- Sept 2028
- Lead sponsor
- Ryazan State Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT06860646
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Sept 2020 to the primary completion date, Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- \- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization.
Age in the registry: 75 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State Budgetary Institution of the Ryazan Region "Regional Clinical Cardiology Dispensary" Coordinator of this site? Confirm its status | Ryazan | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.